EADV 2026: Galderma’s scientific presentations and activities Mittwoch, 23. September 2026 - 06:48

First author or presenter 

Poster title 

Presentation type and further details 

Atopic dermatitis 

Long-term safety and efficacy (up to 152 weeks) of nemolizumab in ARCADIA open-label extension study in adolescents and adults with moderate-to-severe atopic dermatitis  

S. Ständer 

Quantifying the impact of itch and skin lesion severity on quality of life in atopic dermatitis: A longitudinal analysis of the ARCADIA trials  

Atopic dermatitis & prurigo nodularis  

F. Legat 

Comparative effects of itch, skin lesion severity and nemolizumab on sleep disturbance in atopic dermatitis and prurigo nodularis  

Long-term safety profile of nemolizumab over 2 years in moderate-to-severe atopic dermatitis and prurigo nodularis: Post-hoc analysis from ARCADIA LTE and OLYMPIA LTE trials  

H. Lima 

Real-world demographics, clinical characteristics, and itch burden of patients with atopic dermatitis and prurigo nodularis receiving advanced systemic therapy in Canada using artificial intelligence-extracted data  

Prurigo nodularis 

S. Ständer 

Evolution of clinical response with long-term nemolizumab therapy in prurigo nodularis: From symptom relief to improvements in sleep and quality of life  

S. Ständer 

Data-driven conceptual disease model of prurigo nodularis using structural equation modelling  

Acne 

A. Layton 

Assessing skin quality in patients with acne and acne scars through retrospective image analysis of trifarotene’s effects on redness and color evenness  

Sensitive Skin 

J. Conway 

Temporally optimized antioxidant serums for daytime defence and nighttime repair: A multicenter clinical investigation 

N. Zarabian  

Effects of a triple-acid topical formulation on skin hydration and barrier function  

M. Farah 

Skin tone and sensitive skin: An artificial intelligence-driven cross-sectional analysis  

M. Farah  

Artificial intelligence-driven identification of stress, overscheduling, and younger age as high-risk factors for sensitive skin  

N. Zarabian  

A cross-sectional analysis of hidradenitis suppurativa, sensitive skin syndrome, and primary hyperhidrosis as comorbidities  

Acne 

R. Tang 

Clinical and psychosocial outcomes of multi‑active hydrocolloid patch in the management of acne pustules  

N. Zarabian 

Targeting acne-related inflammation: Synergistic inhibition of IL-1β responses by a lysine-based dendritic polymer and niacinamide in human keratinocytes  

N. Zarabian 

Dermatology practitioner approaches to post-isotretinoin acne management  

Dermatoporosis 

G. Ablon  

Efficacy of an innovative cream on biomarkers for aging in mature, fragile skin  

A. Widgerow  

An innovative cream improves signs and symptoms of dermatoporosis in subjects aged 65 and over  

Atopic dermatitis 

M. Sachdev 

A gentle cleanser and barrier-restoring moisturiser regimen in mild to-moderate atopic dermatitis: biophysical, clinical, and quality of life evidence from a prospective baseline-controlled study  

Speakers 

Event type & title  

Details  

Symposium: Advancing treatment outcomes in atopic dermatitis and prurigo nodularis: Targeting the IL-31 neuroimmune pathways 

Industry Expert Hub: Targeting cellular senescence to counter skin aging and dermatoporosis: A science-drive innovation for skin longevity